Literature DB >> 11967321

Strength of envelope protein interaction modulates cytopathicity of measles virus.

Richard K Plemper1, Anthea L Hammond, Denis Gerlier, Adele K Fielding, Roberto Cattaneo.   

Abstract

To understand the molecular determinants of measles virus (MV) cytopathicity, we have characterized mutant viruses exhibiting a more-extensive cell-to-cell fusion while maintaining efficient replication to high titers. A virus which is modified by the addition of an 8-amino-acid Flag epitope tag at the cytoplasmic tail of its H (for MV hemagglutinin) envelope glycoprotein replicates efficiently, has an increased cytopathicity, possesses a greater infectivity per particle, and has an altered protein composition compared with that of unmodified MV. The mutant phenotype is not specifically linked to the epitope sequence, since an alternatively added HA (for influenza virus-derived hemagglutinin) epitope tag caused similar effects. We demonstrate that both epitope tags weaken the interaction between the H and fusion (F) glycoproteins in virus-infected cells. This reduction in strength of H/F interaction is independent of the presence of the viral matrix (M) protein. Viruses with this less stable complex are more sensitive to neutralization by a soluble octameric form of the CD46 receptor, consistent with their increased fusogenicity. Similar analyses of glycoproteins derived from MV strains with reduced cytopathicities confirm that the strength of H and F glycoprotein interaction is a modulator of viral fusogenicity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11967321      PMCID: PMC136138          DOI: 10.1128/jvi.76.10.5051-5061.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism.

Authors:  I C Johnston; V ter Meulen; J Schneider-Schaulies; S Schneider-Schaulies
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

3.  Mutational analysis of conserved domains within the cytoplasmic tail of gp41 from human immunodeficiency virus type 1: effects on glycoprotein incorporation and infectivity.

Authors:  S C Piller; J W Dubay; C A Derdeyn; E Hunter
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Studies on an attenuated measles-virus vaccine. I. Development and preparations of the vaccine: technics for assay of effects of vaccination.

Authors:  J F ENDERS; S L KATZ; M V MILOVANOVIC; A HOLLOWAY
Journal:  N Engl J Med       Date:  1960-07-28       Impact factor: 91.245

5.  Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence.

Authors:  T Cathomen; H Y Naim; R Cattaneo
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  A recombinant measles virus expressing biologically active human interleukin-12.

Authors:  M Singh; M A Billeter
Journal:  J Gen Virol       Date:  1999-01       Impact factor: 3.891

7.  A highly pathogenic simian/human immunodeficiency virus with genetic changes in cynomolgus monkey.

Authors:  K Shinohara; K Sakai; S Ando; Y Ami; N Yoshino; E Takahashi; K Someya; Y Suzaki; T Nakasone; Y Sasaki; M Kaizu; Y Lu; M Honda
Journal:  J Gen Virol       Date:  1999-05       Impact factor: 3.891

8.  Chimeric measles viruses with a foreign envelope.

Authors:  P Spielhofer; T Bächi; T Fehr; G Christiansen; R Cattaneo; K Kaelin; M A Billeter; H Y Naim
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

9.  The human CD46 molecule is a receptor for measles virus (Edmonston strain).

Authors:  R E Dörig; A Marcil; A Chopra; C D Richardson
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

10.  Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation into particles and fusogenicity and infectivity.

Authors:  K Zingler; D R Littman
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

View more
  84 in total

1.  Measles virus glycoprotein complexes preassemble intracellularly and relax during transport to the cell surface in preparation for fusion.

Authors:  Melinda A Brindley; Sukanya Chaudhury; Richard K Plemper
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  The transmembrane domain sequence affects the structure and function of the Newcastle disease virus fusion protein.

Authors:  Kathryn A Gravel; Lori W McGinnes; Julie Reitter; Trudy G Morrison
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

Review 3.  Modes of paramyxovirus fusion: a Henipavirus perspective.

Authors:  Benhur Lee; Zeynep Akyol Ataman
Journal:  Trends Microbiol       Date:  2011-04-20       Impact factor: 17.079

4.  Mutations in the putative HR-C region of the measles virus F2 glycoprotein modulate syncytium formation.

Authors:  Richard K Plemper; Richard W Compans
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

5.  C-terminal tyrosine residues modulate the fusion activity of the Hendra virus fusion protein.

Authors:  Andreea Popa; Cara Teresia Pager; Rebecca Ellis Dutch
Journal:  Biochemistry       Date:  2011-01-20       Impact factor: 3.162

6.  Reversible inhibition of the fusion activity of measles virus F protein by an engineered intersubunit disulfide bridge.

Authors:  Jin K Lee; Andrew Prussia; James P Snyder; Richard K Plemper
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

7.  N-linked glycans with similar location in the fusion protein head modulate paramyxovirus fusion.

Authors:  Veronika von Messling; Roberto Cattaneo
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Interacting domains of the HN and F proteins of newcastle disease virus.

Authors:  Kathryn A Gravel; Trudy G Morrison
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activity.

Authors:  Laura K White; Jeong-Joong Yoon; Jin K Lee; Aiming Sun; Yuhong Du; Haian Fu; James P Snyder; Richard K Plemper
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

10.  Canine distemper virus and measles virus fusion glycoprotein trimers: partial membrane-proximal ectodomain cleavage enhances function.

Authors:  Veronika von Messling; Dragana Milosevic; Patricia Devaux; Roberto Cattaneo
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.